Pall Enters Multi-Million Dollar Contract with Exothera for Viral Vector Manufacturing July 21, 2021 Auto Bot News 0 Pall has secured a manufacturing contract with Exothera for the suspension-based manufacture of gene therapies and viral vector-based vaccines.
